Jennifer K. Simpson - Sep 13, 2021 Form 4 Insider Report for Panbela Therapeutics, Inc. (PBLA)

Role
President and CEO, Director
Signature
/s/ Joshua L. Colburn, Attorney-in-Fact
Stock symbol
PBLA
Transactions as of
Sep 13, 2021
Transactions value $
$0
Form type
4
Date filed
9/15/2021, 06:00 PM
Previous filing
Aug 11, 2021
Next filing
Dec 17, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PBLA Employee Stock Option (right to buy) Award $0 +19.1K $0.00 19.1K Sep 13, 2021 Common Stock 19.1K $2.26 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option is schedule to vest in three equal annual installments on September 13, 2022, 2023 and 2024.